Monitoring the safety of licensed medicines.
- Published in:
- 2005
- By:
- Publication type:
- review
Works matching IS 14741776 AND DT 2005 AND VI 4 AND IP 7
Results: 23
1
2
Patent primer: Added matter and patentability.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 7, p. 531, doi. 10.1038/nrd1781
- By:
- Publication type:
- Article
3
Industry funding of the FDA: effects of PDUFA on approval times and withdrawal rates.
- Published in:
- 2005
- By:
- Publication type:
- review
4
From the analyst's couch: Valuation with cash multiples.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 7, p. 533, doi. 10.1038/nrd1779
- By:
- Publication type:
- Article
5
Solid-state NMR in drug design and discovery for membrane-embedded targets.
- Published in:
- 2005
- By:
- Publication type:
- review
6
Lead discovery: Cell death by design.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 7, p. 539, doi. 10.1038/nrd1785
- By:
- Publication type:
- Article
7
Design and development of polymers for gene delivery.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 7, p. 581, doi. 10.1038/nrd1775
- By:
- Publication type:
- Article
8
The emerging field of lipidomics.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 7, p. 594, doi. 10.1038/nrd1776
- By:
- Publication type:
- Article
9
Ageing and metabolism: drug discovery opportunities.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 7, p. 569, doi. 10.1038/nrd1777
- By:
- Publication type:
- Article
10
Fresh from the pipeline: Entecavir.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 7, p. 535, doi. 10.1038/nrd1780
- By:
- Publication type:
- Article
11
Bacterial sepsis: Pepducins to the rescue.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 7, p. 538, doi. 10.1038/nrd1782
- By:
- Publication type:
- Article
12
Caution remains over stem cells despite breakthrough.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 7, p. 527, doi. 10.1038/nrd1790
- By:
- Publication type:
- Article
13
In Brief.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 7, p. 540, doi. 10.1038/nrd1783
- Publication type:
- Article
14
Susan Desmond-Hellmann.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 7, p. 532, doi. 10.1038/nrd1794
- By:
- Publication type:
- Article
15
Infectious diseases: Double trouble.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 7, p. 538, doi. 10.1038/nrd1784
- By:
- Publication type:
- Article
16
Patentwatch: Pharma allowed to make own generics.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 7, p. 530, doi. 10.1038/nrd1793
- By:
- Publication type:
- Article
17
Drug delivery: Transferrin' the load.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 7, p. 537, doi. 10.1038/nrd1786
- By:
- Publication type:
- Article
18
Medicinal chemistry: Best of both worlds?
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 7, p. 540, doi. 10.1038/nrd1787
- By:
- Publication type:
- Article
19
Incentive to be inventive.
- Published in:
- 2005
- Publication type:
- Editorial
20
Big companies helped by safe harbour ruling.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 7, p. 525, doi. 10.1038/nrd1789
- By:
- Publication type:
- Article
21
News In Brief.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 7, p. 528, doi. 10.1038/nrd1791
- Publication type:
- Article
22
Patentwatch: EC fines AstraZeneca in Losec antitrust case.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 7, p. 530, doi. 10.1038/nrd1792
- By:
- Publication type:
- Article
23
In This Issue.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 7, p. 521, doi. 10.1038/nrd1795
- Publication type:
- Article